ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

Choosing Second-Line Therapy for Patients With Urothelial Carcinoma

Sumanta K. Pal, MD
Published Online:2:59 PM, Tue October 10, 2017

Sumanta K. Pal, MD, medical oncologist, assistant clinical professor, Department of Medical Oncology and Therapeutics Research, City of Hope, discusses choosing second-line therapy for patients with urothelial carcinoma.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.